Market Access Strategies for APAC Biosimilars

Market access in pharmaceuticals has evolved from being merely price and reimbursement centric to ...

Innovators 2015: Companies

PM360’s Innovations Issue, established four years ago, serves as a comprehensive guide to our readers, providing ...

Emerging Targets: Care Partners, Underserved Communities, Health Activists

The pharmaceutical industry has always taken a multi-pronged approach to communication. But for a ...

5 Challenges Influencing Market Access for Specialty Biologics

Specialty biologics are the fastest growing class of bio/pharmaceutical products, and not without reason. ...

Can the Shine be Restored to Pharma’s Tarnished Reputation Crown?

Hydro-fracturing (i.e., fracking) and tobacco have long endured societal disdain. Tolerating public abuse has ...

Time To Go Virtual?

Pharma brand management is increasingly challenging these days. Doctors don’t have time to meet ...

Inside INTREpreneurship

Being Entrepreneurial in a Corporate Environment At the very basic level entrepreneurs and corporations ...